Depomed (NASDAQ:DEPO) reported Q1 2018 earnings this Afternoon, coming in at $0.28 per share, beating Wall Street’s estimates of $0.12 per Share. Revenue for the quarter came in at $128.40 million missing the streets estimates of $65.77 million Recent Insider Trading for Depomed (NASDAQ:DEPO)
- On 3/7/2018 Matthew M. Gosling, SVP, sold 45,519 with an average share price of $6.58 per share and the total transaction amounting to $299,515.02.
- On 12/14/2017 Arthur J. Higgins, Insider, bought 75,000 with an average share price of $8.16 per share and the total transaction amounting to $612,000.00.
- On 6/12/2017 Arthur J Higgins, Insider, bought 15,000 with an average share price of $9.92 per share and the total transaction amounting to $148,800.00.
- On 11/14/2016 August J Moretti, CFO, sold 5,000 with an average share price of $20.84 per share and the total transaction amounting to $104,200.00.
- On 9/21/2016 Thadd M Vargas, VP, sold 11,250 with an average share price of $25.00 per share and the total transaction amounting to $281,250.00.
- On 8/10/2016 August J. Moretti, CFO, sold 5,000 with an average share price of $21.40 per share and the total transaction amounting to $107,000.00.
Dividend History for Depomed (NASDAQ:DEPO)
Recent Trading for Depomed (NASDAQ:DEPO) Shares of Depomed closed the previous trading session at 7.28 up +1.32 22.15% with 6.570000171661377 shares trading hands.